Skip to main content
. 2022 May 27;14(11):2182. doi: 10.3390/polym14112182

Figure 9.

Figure 9

A combined four-nozzle organ three-dimensional (3D) bioprinting technology created at Tsinghua Unversity in Prof. Wang’s laboratory in 2013 [99]: (a) equipment of the combined four-nozzle organ 3D bioprinter; (b) working state of the combined four-nozzle organ 3D printer; (c) a computer aided design (CAD) model representing a large scaled-up vascularized and innervated hepatic tissue; (d) a semi-ellipse 3D construct containing a poly (lactic acid-co-glycolic acid) (PLGA) overcoat, a hepatic tissue made from hepatocytes in a gelatin/chitosan hydrogel, a branched vascular network with fully confluent endothelialized adipose-derived stem cells (ASCs) on the inner surface of the gelatin/alginate/fibrin hydrogel and a hierarchical neural (or innervated) network made from Schwann cells in the gelatin/hyaluronate hydrogel, the maximal diameter of the semi-ellipse can be adjusted from 1 mm to 2 cm according to the CAD model; (e) a cross section of (d), showing the endothelialized ASCs and Schwann cells around a branched channel; (f) a large bundle of nerve fibers formed in (d); (g) hepatocytes underneath the PLGA overcoat; (h) an interface between the endothelialized ASCs and Schwann cells in (d); (i) some thin nerve fibers.